![]() |
市场调查报告书
商品编码
1447137
到 2030 年椎间盘髓核置换术市场预测:按手术类型、材料、椎体位置、技术、最终用户和地区进行的全球分析Spinal Laminoplasty Market Forecasts to 2030 - Global Analysis By Surgery Type, By Material (Polyetheretherketone Implants, Titanium Implants and Tantalum Implants), Vertebral Position, Technology, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球椎板椎间盘髓核置换术市场规模为 59.8 亿美元,预计在预测期内复合年增长率为 5.5%,到 2030 年将达到 87.1 亿美元。
椎间盘髓核置换术是一种透过扩大脊椎来治疗颈椎脊椎狭窄的外科手术。在层骨的一侧创建铰链併升高以允许脊髓和神经减压。此方法可以维持脊髓的稳定性,同时缓解脊髓受压引起的疼痛、麻木、无力等症状。
根据 2021 年发表的一项研究,美国大约进行了 50 万例腰椎手术。
脊椎狭窄盛行率上升
脊椎狭窄盛行率的上升是椎间盘髓核置换术市场的关键驱动因素。脊椎狭窄的特征是脊椎变窄,导致脊髓和神经受压,引起疼痛、麻木和无力等症状。脊椎椎间盘髓核置换术,越来越多地被采用作为脊椎狭窄患者的治疗选择。患者数量的增加正在推动椎间盘髓核置换术和相关医疗设备的需求,从而推动市场成长。
昂贵的治疗费用
患者在接受照护时可能面临经济障碍,尤其是在医疗保险有限或自付费用较高的地区。此外,医疗保健提供者和设施可能在报销和与付款人进行价格谈判方面面临挑战,影响他们提供负担得起的服务的能力。这些成本障碍阻碍了患者寻求或完成治疗,并限制了椎间盘髓核置换术的整体市场潜力。
人们对微创手术的认识不断增强
微创手术与传统开放性手术相比具有优势,包括减少术后疼痛、缩短住院时间和加快復原时间。随着患者对这些益处的了解越来越多,对微创脊椎手术(包括椎间盘髓核置换术)的需求正在增加。这一趋势正在推动手术技术和手术的创新,鼓励医疗保健提供者采用微创方法并扩大其在椎间盘髓核置换术市场的产品范围。
椎间盘髓核置换术相关的併发症
椎间盘髓核置换术相关的併发症对市场构成重大威胁。这些併发症,包括神经损伤、感染疾病和脊椎不稳定,可能导致术后併发症和患者不满意。此外,再次手术和长期併发症的风险可能会阻止患者和医疗保健提供者选择分层作为治疗方案。此外,负面结果可能会损害该手术的声誉,降低其采用率,并影响椎间盘髓核置换术市场的成长前景。
COVID-19 的爆发扰乱了择期手术并减少了患者使用医疗机构的机会,从而影响了椎间盘髓核置换术市场。封锁措施和疫情管理资源的重新分配导致非紧急脊椎手术被推迟。结果,提供椎间盘髓核置换术服务的医疗保健提供者的手术数量和收益减少。
开放椎间盘髓核置换术术领域预计将成为预测期内最大的领域
在预测期内,椎间盘髓核置换术市场预计将以开放椎间盘髓核置换术为主。这是因为开放式椎间盘髓核置换术是一种已使用多年的成熟手术技术。此外,与微创技术相比,开放椎间盘髓核置换术可以实现脊髓的可视化和减压。此外,外科医生对熟悉且经过验证的手术方法的偏好也促进了脊椎手术中开放式椎间盘髓核置换术的持续需求。
预计 3D 列印产业在预测期内的复合年增长率最高。
预计 3D 列印领域在预测期内将在椎间盘髓核置换术市场中呈现最高成长率。这一增长是由 3D 列印技术的进步推动的,该技术能够生产根据个体解剖结构量身定制的患者专用植入和手术器械。此外,3D 列印还具有提高手术精度、缩短製造时间和降低成本等优点。这些因素促使 3D 列印在椎间盘髓核置换术中得到越来越多的采用,并推动市场成长。
由于其先进的医疗基础设施、脊椎疾病的高盛行率以及较早采用创新医疗技术,北美在椎间盘髓核置换术市场中占据了最大的市场占有率。此外,强有力的报销政策和有利的医疗保健法规支持脊椎手术在北美的普及。此外,领先的医疗设备公司和知名医疗机构的入驻进一步加强了该地区在椎板椎间盘髓核置换术市场的主导地位。
由于脊椎疾病盛行率的增加、医疗保健成本的上升以及先进医疗设施的普及,亚太地区的椎板椎间盘髓核置换术市场预计将快速成长。此外,医疗基础设施的改善和脊椎健康意识的提高正在推动对椎间盘髓核置换术等手术干预的需求。此外,该地区人口众多、人口老化导致患者数量众多,为亚太市场脊椎手术带来了成长机会。
According to Stratistics MRC, the Global Spinal Laminoplasty Market is accounted for $5.98 billion in 2023 and is expected to reach $8.71 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Spinal laminoplasty is a surgical procedure used to treat cervical spinal stenosis by enlarging the spinal canal. It involves creating a hinge on one side of the lamina bone and lifting it, allowing decompression of the spinal cord and nerves. This technique preserves spinal stability while providing relief from symptoms such as pain, numbness, and weakness caused by spinal cord compression.
According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US.
Rising prevalence of spinal stenosis
The rising prevalence of spinal stenosis serves as a significant driver in the spinal laminoplasty market. Spinal stenosis, characterized by the narrowing of the spinal canal, leads to compression of the spinal cord and nerves, causing symptoms like pain, numbness, and weakness. Spinal laminoplasty, a surgical procedure aimed at alleviating spinal cord compression, is increasingly adopted as a treatment option for patients with spinal stenosis. This growing patient population drives demand for laminoplasty procedures and related medical devices, fostering market growth.
High cost of procedures
Patients may face financial barriers to accessing treatment, especially in regions with limited healthcare coverage or high out-of-pocket expenses. Additionally, healthcare providers and facilities may experience challenges in reimbursement and pricing negotiations with payers, impacting their ability to offer affordable services. This cost barrier can deter patients from seeking or completing treatment, thereby limiting the overall market potential for spinal laminoplasty procedures.
Growing awareness of minimally invasive surgeries
Minimally invasive techniques offer advantages such as reduced post-operative pain, shorter hospital stays, and quicker recovery times compared to traditional open surgeries. As patients become more informed about these benefits, there is a rising demand for minimally invasive spinal procedures, including laminoplasty. This trend drives innovation in surgical technologies and techniques, encouraging healthcare providers to adopt minimally invasive approaches and expand their offerings in the spinal laminoplasty market.
Complications associated with spinal laminoplasty
The complications associated with spinal laminoplasty pose a significant threat to the market. These complications, including nerve damage, infection, and instability of the spine, can lead to post-operative complications and patient dissatisfaction. Moreover, the risk of reoperation and long-term complications may deter both patients and healthcare providers from choosing laminoplasty as a treatment option. Additionally, negative outcomes can damage the reputation of the procedure and decrease its adoption rate, impacting the growth prospects of the spinal laminoplasty market.
The COVID-19 pandemic has impacted the spinal laminoplasty market by disrupting elective surgeries and reducing patient access to healthcare facilities. Lockdown measures and reallocation of resources towards managing the pandemic led to the postponement of non-urgent spinal procedures. This resulted in decreased procedural volumes and revenue for healthcare providers offering spinal laminoplasty services.
The open laminoplasty segment is expected to be the largest during the forecast period
Over the forecast period, the open laminoplasty segment is anticipated to dominate the spinal laminoplasty market. This is attributed to the long-standing use of and established surgical techniques associated with open laminoplasty procedures. Additionally, open laminoplasty allows for greater visualization and decompression of the spinal cord compared to minimally invasive techniques. Furthermore, the preference for familiar and proven surgical methods by surgeons contributes to the sustained demand for open laminoplasty procedures in spinal surgery.
The 3D printing segment is expected to have the highest CAGR during the forecast period
The 3D printing segment is projected to witness the highest growth rate in the spinal laminoplasty market during the forecast period. This growth is driven by advancements in 3D printing technology, enabling the production of patient-specific implants and surgical instruments tailored to individual anatomies. Additionally, 3D printing offers benefits such as improved surgical precision, faster production times, and reduced costs. These factors contribute to the increasing adoption of 3D printing in spinal laminoplasty procedures, fueling market growth.
North America is positioned to secure the largest market share in the spinal laminoplasty market due to the region's advanced healthcare infrastructure, high prevalence of spinal disorders, and early adoption of innovative medical technologies. Additionally, robust reimbursement policies and favorable healthcare regulations support the uptake of spinal procedures in North America. Moreover, the presence of leading medical device companies and renowned healthcare institutions further strengthens the region's dominance in the spinal laminoplasty market.
The Asia-Pacific region is poised for rapid growth in the spinal laminoplasty market owing to the increasing prevalence of spinal disorders, rising healthcare expenditures, and expanding access to advanced medical facilities. Additionally, improving healthcare infrastructure and growing awareness about spinal health drive demand for surgical interventions like laminoplasty. Moreover, the region's large population and aging demographics create a substantial patient pool, contributing to the growth opportunities for spinal procedures in the Asia-Pacific market.
Key players in the market
Some of the key players in Spinal Laminoplasty Market include Aesculap, Inc., Alphatec Holdings, Inc., Amedica Corporation, Captiva Spine, CoreLink, LLC, DePuy Synthes, Globus Medical Inc., Joimax GmbH, Medtronic plc, Nexxt Spine LLC, NuVasive, Inc., Orthofix Medical Inc., Osseus Fusion Systems, RTI Surgical Holdings, Inc., Spinal Elements, Inc., Spineart, Stryker Corporation, Ulrich Medical and Zimmer Biomet Holdings, Inc.
In October 2023, Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TriLEAP(TM) Lower Extremity Anatomic Plating System, a comprehensive yet modular, procedure-specific system designed to meet the complex needs of orthopaedic surgeons, doctors of podiatric medicine, and foot and ankle specialists. The TriLEAP(TM) System provides a diverse offering of contoured and conventional plates that can accommodate multiple screw diameters, and instruments that can be used during the reduction, internal fixation and fusion of bones and bone fragments.
In September 2023, Globus Medical, Inc., a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc. The combined company will provide surgeons and patients with one of the most comprehensive offerings of musculoskeletal procedural solutions and enabling technologies to impact the care continuum.
In December 2022, Captiva Spine announces an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics, adding to their expanding product portfolio. For underserved hospitals and Ambulatory Surgery Centers (ASCs) throughout the U.S., this technology will serve as a platform to expand the company's products and services with enhanced enabling technology to support MIS technology. Specifically, Captiva Spine will be starting with their CapLOX Pedicle Screws, TowerLOX-EXT MIS Extended Tab Pedicle Screws, and TransFasten Posterior SI joint fusion system.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.